Results 151 to 160 of about 434,626 (386)

Association of multiple mutations in NS5A and NS5B genes and resistance to direct-acting antivirals in chronically infected Egyptian patients with Hepatitis C virus Genotype 4a [PDF]

Novel Research in Microbiology Journal
Approximately 71 million people worldwide are supposed to have chronic hepatitis C virus (CHCV). New direct-acting antiviral (DAA) medications have been used, which helped successfully in complete treatment of CHCV and achieved a sustained virological ...
Gehad M. Mohamed, Ahmed B. Barakat, Marwa M. Gado, Fatma M. Abdallah   +3 more
doaj   +1 more source

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect

Nature, 2010
The worldwide prevalence of chronic hepatitis C virus (HCV) infection is estimated to be approaching 200 million people. Current therapy relies upon a combination of pegylated interferon-α and ribavirin, a poorly tolerated regimen typically associated ...
M. Gao, R. Nettles, M. Belema, L. Snyder, V. Nguyen, R. Fridell, Michael H. Serrano-Wu, D. Langley, Jin‐Hua Sun, Donald R. O’Boyle II, J. Lemm, Chunfu Wang, J. Knipe, C. Chien, R. Colonno, D. Grasela, N. Meanwell, L. Hamann   +17 more
semanticscholar   +1 more source

HCV-RNA and Anti-HCV IgM in Egyptian Subjects Bearing IgG Anti-HCV Antibodies

Japanese Journal of Infectious Diseases, 1999
The hepatitis C virus (HCV) infection is associated with a wide spectrum of clinical entities ranging from asymptomatic carriage to severe forms of chronic hepatitis. In Egypt, HCV infection has been shown to be highly prevalent. The aim of this study was to determine the frequency and significance of anti-HCV IgM in the sera of clinically healthy ...
A, el-Gohary, A M, Hosny, N, Fawaz, A, Heiba, E, Abdalla, F, Kawano, T, Kiyokawa   +6 more
openaire   +3 more sources

Nanoparticles in microdroplets: Recent advances in microfluidic generators for producing functional microbeads

Droplet, EarlyView.
Functional hybrid microbeads with electrical, magnetic, and/or optical responsiveness have emerged as versatile platforms for biotechnology. This review highlights recent advances in microfluidic technologies for producing such microbeads, with a focus on incorporating functional nanoparticles in microdroplet systems.
  Bayinqiaoge, Chengchen Zhang, Shi‐Yang Tang   +2 more
wiley   +1 more source

Boceprevir for Untreated Chronic HCV Genotype 1 Infection

New England Journal of Medicine, 2011
Sprint Investigators
semanticscholar   +2 more sources

Seroprevalence and Associated Factors of Hepatitis B and Hepatitis C Viral Infections Among Prisoners in Tigrai, Northern Ethiopia

Infection and Drug Resistance, 2023
Belaynesh Tsegay,1 Teklay Gebrecherkos,2 Atsebaha Gebrekidan Kahsay,2 Mahmud Abdulkader2 1Ayder Comprehensive Specialized Hospital Laboratory Department, Mekelle University, Mekelle, Tigrai, Northern Ethiopia; 2Department of Medical Microbiology and ...
Tsegay B, Gebrecherkos T, Kahsay AG, Abdulkader M   +3 more
doaj  

Impact Of Hepatitis C Co-Infection On CD4 Cell Count In HIV Infected Subjects [PDF]

, 2008
Background: Human immunodeficiency virus (HIV) and Hepatitis C virus (HCV) co-infection is reported to be common among HIV infected subjects due to share routes of transmission.
Emokpae, MA, Jegede, EE, Nwokedi, EE
core  

Coinfección HBV-HCV y HIV-HCV

Acta Gastroenterológica Latinoamericana, 2005
...
Fernando Bessone, Hugo Fainboim, Eduardo Fassio   +2 more
openaire   +1 more source

Optimizing ribavirin dose in HIV/hepatitis C (HCV) co‐infected individuals treated for HCV [PDF]

, 2012
John Farley, A. Truong, Gábor Horváth, Thuy Nguyen, Weng‐Yoon Shum   +4 more
openalex   +1 more source

Efficacy and safety of direct-acting antiviral agents for HCV in mild-to-moderate chronic kidney disease

, 2020
Ezequiel Ridruejo, Rebeca García-Agudo, Manuel Mendizábal, Sami Aoufi-Rabih, Vivek Dixit, Marcelo Silva, Fabrizio Fabrizi   +6 more
openalex   +1 more source